These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12610180)

  • 21. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 17p allelic loss in colorectal carcinoma. Clinical significance.
    Takanishi DM; Angriman I; Yaremko ML; Montag A; Westbrook CA; Michelassi F
    Arch Surg; 1995 Jun; 130(6):585-8; discussion 588-9. PubMed ID: 7763165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
    Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
    Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.
    Arango D; Laiho P; Kokko A; Alhopuro P; Sammalkorpi H; Salovaara R; Nicorici D; Hautaniemi S; Alazzouzi H; Mecklin JP; Järvinen H; Hemminki A; Astola J; Schwartz S; Aaltonen LA
    Gastroenterology; 2005 Sep; 129(3):874-84. PubMed ID: 16143127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
    Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
    J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
    Watanabe T; Wu TT; Catalano PJ; Ueki T; Satriano R; Haller DG; Benson AB; Hamilton SR
    N Engl J Med; 2001 Apr; 344(16):1196-206. PubMed ID: 11309634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of genetic variants in preneoplastic areas of colorectal tumours.
    Lindforss U; Papadogiannakis N; Zetterquist H; Lindberg G; Olivecrona H
    Eur J Surg Oncol; 2003 Aug; 29(6):491-6. PubMed ID: 12875854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma.
    Offerhaus GJ; De Feyter EP; Cornelisse CJ; Tersmette KW; Floyd J; Kern SE; Vogelstein B; Hamilton SR
    Gastroenterology; 1992 May; 102(5):1612-9. PubMed ID: 1568571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
    Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
    Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
    Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
    J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer.
    Curran B; Lenehan K; Mulcahy H; Tighe O; Bennett MA; Kay EW; O'Donoghue DP; Leader M; Croke DT
    Gut; 2000 Feb; 46(2):200-4. PubMed ID: 10644313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
    Russo A; Bazan V; Iacopetta B; Kerr D; Soussi T; Gebbia N;
    J Clin Oncol; 2005 Oct; 23(30):7518-28. PubMed ID: 16172461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer.
    Khine K; Smith DR; Goh HS
    Cancer; 1994 Jan; 73(1):28-35. PubMed ID: 8275434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.
    Font A; Abad A; Monzó M; Sanchez JJ; Guillot M; Manzano JL; Piñol M; Ojanguren I; Rosell R
    Dis Colon Rectum; 2001 Apr; 44(4):549-57. PubMed ID: 11330582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
    Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
    Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma.
    Miki C; Tonouchi H; Wakuda R; Hatada T; Inoue Y; Minato E; Kobayashi M; Kusunoki M
    Cancer; 2002 Mar; 94(5):1584-92. PubMed ID: 11920517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
    Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
    Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.
    Oliva MR; Ripoll F; Muñiz P; Iradi A; Trullenque R; Valls V; Drehmer E; Sáez GT
    Mol Carcinog; 1997 Apr; 18(4):232-43. PubMed ID: 9142218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.